Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
- 1 June 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 361 (9374), 2024-2031
- https://doi.org/10.1016/s0140-6736(03)13638-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)Jama-Journal Of The American Medical Association, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol loweringThe American Journal of Cardiology, 2000
- Cancer incidence in a kidney-transplanted populationTransplant International, 2000
- CHOLESTEROL AS AN INDEPENDENT PREDICTOR OF OUTCOME AFTER RENAL TRANSPLANTATIONTransplantation, 2000
- Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience. REVIEW ARTICLEJournal of Clinical Pharmacy & Therapeutics, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- IMPACT OF SERUM LIPIDS ON LONG-TERM GRAFT AND PATIENT SURVIVAL AFTER RENAL TRANSPLANTATION1Transplantation, 1995
- Hyperlipidaemia in renal transplantation—risk factor for long-term graft outcomeEuropean Journal of Clinical Investigation, 1995